The benchmark S&P/ASX 200 [ASX:XJO] is inching higher on Tuesday morning, propelled by a rebounding iron ore price which pushed the big miners Fortescue Metals Group [ASX:FMG] and Rio Tinto [ASX:RIO] higher.
The Paradigm Biopharmaceuticals Ltd [ASX:PAR] share price is up more than 4%, trading at $2.51. The PAR share price has largely traded sideways since October...
At time of writing, the share price of Paradigm Biopharmaceuticals Limited [ASX:PAR] is up 11.74%, trading at $1.475 per share. The latest news out of the company is in regards to a successful phase 2b clinical trial of its knee pain injection.
Paradigm Biopharmaceuticals [ASX:PAR] wiped 52.86% off its share price today, after a less-than-stellar update from one of its clinical trials. What happened?